Global Pharmaceuticals & Biotech Big Green Snowflakes

Biogen

Market Cap: US$20.5b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Illumina

Market Cap: US$15.0b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Shanghai New World

Market Cap: CN¥5.1b

Owns and operates department stores in China.

ALTEOGEN

Market Cap: ₩25.4t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

GNI Group

Market Cap: JP¥148.4b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Shandong Xinhua Pharmaceutical

Market Cap: HK$10.4b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

Anthem Biosciences

Market Cap: ₹466.0b

Operates as technology-focused contract research, development, and manufacturing organization.

SMO ClinPlusLTD

Market Cap: CN¥3.9b

Provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China.

Alembic Pharmaceuticals

Market Cap: ₹186.0b

An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.

Jinyu Bio-technology

Market Cap: CN¥9.1b

Develops and evaluates vaccines and reagents for animal diseases.

SPM

Market Cap: ₫149.4b

Manufactures and sells pharmaceutical products in Vietnam.

Asston Pharmaceuticals

Market Cap: ₹851.3m

Engages in the manufacturing and selling of pharmaceutical formulations and nutraceutical products in India, West Africa, South Africa, and rest of Asia.

Pharmesis International

Market Cap: S$14.4m

An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.

Vitrolife

Market Cap: SEK 18.6b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Psyence Biomedical

Market Cap: US$1.5m

Engages in the development of botanical psilocybin-based psychedelic medicines.

Supernus Pharmaceuticals

Market Cap: US$2.5b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Gubra

Market Cap: DKK 6.5b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

InflaRx

Market Cap: US$106.4m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

ArcticZymes Technologies

Market Cap: NOK 1.4b

A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م891.2m

Develops, produces, and sells pharmaceutical products in Egypt.

Norda

Market Cap: NOK 415.7m

A biotechnology company, engages in the cancer diagnostic activities.

Champions Oncology

Market Cap: US$95.3m

A technology-enabled research company, provides technology solutions for drug discovery and development in the United States.

Xbrane Biopharma

Market Cap: SEK 670.1m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Neuren Pharmaceuticals

Market Cap: AU$2.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Bal Pharma

Market Cap: ₹1.4b

Manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.

Cenra

Market Cap: NT$5.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Inner Mongolia Furui Medical Science

Market Cap: CN¥17.1b

Inner Mongolia Furui Medical Science Co., Ltd.

Sunrest Lifescience

Market Cap: ₹211.1m

Engages in the trading, wholesale, and retail of pharmaceutical products in India.

Akums Drugs and Pharmaceuticals

Market Cap: ₹70.5b

Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.

Shilpa Medicare

Market Cap: ₹82.5b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.9b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.

Cutia Therapeutics

Market Cap: HK$3.7b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

Haw Par

Market Cap: S$3.2b

Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.

3D Global Biotech

Market Cap: NT$3.9b

Develops medical materials for human body reconstruction in China.

Guizhou Xinbang Pharmaceutical

Market Cap: CN¥6.9b

Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.

Hester Biosciences

Market Cap: ₹18.1b

Manufactures and trades in veterinary vaccines and animal health products in India and internationally.